Trade Summary

6 days ago, Wong Hing C, serving as Chief Executive Officer at HCW Biologics Inc. (HCWB), purchased 23,210 shares at $2.59 per share, for a total transaction value of $59,997.85. Following this transaction, Wong Hing C now holds 125,845 shares of HCWB.

This purchase represents a 22.61% increase in Wong Hing C's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Wednesday, July 29, 2026 and publicly disclosed via SEC Form 4 filing on Friday, July 31, 2026 at 4:10 PM ET, 2 days after the trade was made.

HCW Biologics Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.